Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD

Respiratory Medicine

Volumn 99, Issue 1, 2005, Pages 20-26

  Brandén, Eva ^a   Koyi, Hirsh ^a   Gnarpe, Judy ^b   Gnarpe, Håkan ^c   Tornling, Göran ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UPPSALA UNIVERSITY   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

Chlamydia pneumoniae; Chronic Obstructive Pulmonary Disease; Spirometry

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ACUTE DISEASE; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; BACTERIAL PNEUMONIA; BRONCHOSCOPY; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; EMPHYSEMA; EPIDEMIOLOGICAL DATA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; LOWER RESPIRATORY TRACT INFECTION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; SEX DIFFERENCE; SMALL AIRWAY DISEASE; SPIROMETRY; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ADULT; AGE FACTORS; AGED; ANTIBODIES, BACTERIAL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; VITAL CAPACITY;

EID: 10944264671     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.04.014     Document Type: Article

References (37)

1. Stang P. Lydick E. Silberman C. Kempel A. Keating E.T. The prevalence of COPD: Using smoking rates to estimate disease frequency in the general population Chest 117 5 Suppl 2 2000 354S-359S
2. 1. The Lung Health Study JAMA 272 19 1994 1497-1505
3. Matsuse T. Hayashi S. Kuwano K. Keunecke H. Jefferies W.A. Hogg J.C. Latent adenoviral infection in the pathogenesis of chronic airways obstruction Am Rev Respir Dis 146 1 1992 177-184
4. Koyi H. Brandén E. Gnarpe J. Gnarpe H. Steen B. An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study APMIS 109 2001 572-580
5. Falck G. Heyman L. Gnarpe J. Gnarpe H. Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis Scand J Infect Dis 26 2 1994 179-187
6. Gnarpe J. Lundbäck A. Gnarpe H. Sundelöf B. Comparison of nasopharyngeal and throat swabs for the detection of Chlamydia pneumoniae and Mycoplasma pneumoniae by polymerase chain reaction Scand J Infect Dis 104 Suppl. 1997 11-12
7. Gnarpe J. Eriksson K. Sample preparation for Chlamydia pneumoniae PCR APMIS 103 4 1995 307-308
8. Campbell L.A. Perez Melgosa M. Hamilton D.J. Kuo C.C. Grayston J.T. Detection of Chlamydia pneumoniae by polymerase chain reaction J Clin Microbiol 30 2 1992 434-439
9. Naas J. Gnarpe J.A. Demonstration of Chlamydia pneumoniae in tissue by immunohistochemistry APMIS 107 9 1999 882-886
10. ATS. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987;136(1):225-244
11. Berglund E. Birath G. Bjure J. et al. Spirometric studies in normal subjects Acta Med Scand 173 1963 185-192
12. Von Hertzen L. Alakarppa H. Koskinen R. et al.Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease Epidemiol Infect 118 2 1997 155-164
13. Falck G. Gnarpe J. Hansson L.O. Svardsudd K. Gnarpe H. Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: Respiratory morbidity and the metabolic syndrome Chest 122 5 2002 1587-1593
14. Strachan D.P. Carrington D. Mendall M. Butland B.K. Yarnell J.W. Elwood P. Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease Am J Respir Crit Care Med 161 2 Pt 1 2000 493-497
15. Dowell S.F. Peeling R.W. Boman J. et al. Standardizing Chlamydia pneumoniae assays: Recommendations from the centers for disease control and prevention (USA) and the laboratory centre for disease control (Canada) Clin Infect Dis 33 4 2001 492-503
16. Hahn D.L. Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association Arterioscler Thromb 12 8 1992 945-947
17. Karvonen M. Tuomilehto J. Pitkaniemi J. Naukkarinen A. Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity Int J Epidemiol 23 6 1994 1315-1321
18. Grayston J.T. Campbell L.A. Kuo C.C. et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain twar J Infect Dis 161 4 1990 618-625
19. Gnarpe H. Gnarpe J. Lundback A. Evidence of 2 waves of Chlamydia pneumoniae infection in Gavle, Sweden, 1990-96 Scand J Infect Dis 31 1 1999 83-86
20. Tomasi T.B. Grey H.M. Structure and function of immunoglobulin A Prog Allergy 16 1972 81-213
21. Saikku P. Leinonen M. Tenkanen L. et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study Ann Intern Med 116 4 1992 273-278
22. Toss H. Gnarpe J. Gnarpe H. Siegbahn A. Lindahl B. Wallentin L. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease Eur Heart J 19 4 1998 570-577
23. Blasi F. Legnani D. Lombardo V.M. et al. Chlamydia pneumoniae infection in acute exacerbations of COPD Eur Respir J 6 1 1993 19-22
24. Mogulkoc N. Karakurt S. Isalska B. et al. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection Am J Respir Crit Care Med 160 1 1999 349-353
25. Gnarpe J. Gnarpe H. Sundelof B. Endemic prevalence of Chlamydia pneumoniae in subjectively healthy persons Scand J Infect Dis 23 3 1991 387-388
26. Gaydos C.A. Roblin P.M. Hammerschlag M.R. et al. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients J Clin Microbiol 32 4 1994 903-905
27. Wong K.H. Skelton S.K. Chan Y.K. Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract J Clin Microbiol 30 7 1992 1625-1630
28. Yang Z.P. Cummings P.K. Patton D.L. Kuo C.C. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice J Infect Dis 170 2 1994 464-467
29. Gaydos C.A. Summersgill J.T. Sahney N.N. Ramirez J.A. Quinn T.C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells Infect Immun 64 5 1996 1614-1620
30. Shemer-Avni Y. Lieberman D. Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells J Infect Dis 171 5 1995 1274-1278
31. Wu L. Skinner S.J. Lambie N. Vuletic J.C. Blasi F. Black P.N. Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 3 Pt 1 2000 1148-1151
32. Theegarten D. Mogilevski G. Anhenn O. Stamatis G. Jaeschock R. Morgenroth K. The role of Chlamydia in the pathogenesis of pulmonary emphysema. Electron microscopy and immunofluorescence reveal corresponding findings as in atherosclerosis Virchows Arch 437 2 2000 190-193
33. Rodel J. Woytas M. Groh A. et al. Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae Infect Immun 68 6 2000 3635-3641
34. Beatty W.L. Byrne G.I. Morrison R.P. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease Trends Microbiol 2 3 1994 94-98
35. Barnes P.J. Chronic obstructive pulmonary disease N Engl J Med 343 4 2000 269-280
36. Redecke V. Dalhoff K. Bohnet S. Braun J. Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response Am J Respir Cell Mol Biol 19 5 1998 721-727
37. Kol A. Sukhova G.K. Lichtman A.H. Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression Circulation 98 4 1998 300-307